financetom
Business
financetom
/
Business
/
Exclusive-Trump's Paris AI summit delegation won't include AI Safety Institute staff, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Trump's Paris AI summit delegation won't include AI Safety Institute staff, sources say
Feb 6, 2025 2:51 PM

(Reuters) -The U.S. delegation to a major artificial intelligence summit in Paris next week will not include technical staff from the country's AI Safety Institute, two people close to Washington's plans for the event and a third source briefed on the matter told Reuters.

Vice President JD Vance is leading the U.S. contingent to France, which is gathering around 100 countries to focus on AI's potential on February 10 and 11.

U.S. attendees will include members of the White House Office of Science and Technology Policy: Principal Deputy Director Lynne Parker and Senior Policy Advisor for Artificial Intelligence Sriram Krishnan, an OSTP spokesperson said.

However, President Donald Trump's administration has scrapped plans for Homeland Security and Commerce Department officials to attend. Among those whose trips were canceled include representatives of the U.S. AI Safety Institute, said the people close to Washington's plans, who spoke on condition of anonymity.

The AI Safety Institute did not immediately comment. The Commerce and Homeland Security departments did not immediately respond to a request for comment.

The institute, created under former President Joe Biden, is focused on measuring and mitigating certain risks from AI and has signed agreements with prominent U.S. startups OpenAI and Anthropic for safety testing. It has said its work is bipartisan.

However, the new administration's plans for the fledgling body, now without a director, remain unclear. Trump has revoked a separate AI executive order associated with Biden.

The people cautioned that the Paris absence likely reflected how the Commerce Department, in which the institute resides, was still in transition after Trump's January 20 inauguration.

The Paris summit also is less focused than prior global gatherings in Bletchley Park and Seoul on the dangers of AI, risks dismissed by some in the technology sector.

The International Network of AI Safety Institutes, chaired by the United States and comprised of various country members globally, is expected to have a presence, the people said. Its long-in-progress work has involved the U.S.

U.S. delegates could take part in the network's discussions, the people said. Ensuring Washington leads on innovation has become more critical with China's recent success in AI, the people said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Apr 13, 2026
Regulatory Milestone Clears Path to Shareholder Vote and Transaction Completion. ATLANTA & RENO, Nev.--(BUSINESS WIRE)-- Volato Group, Inc. ( SOAR ) (the “Company” or “Volato”) and M2i Global, Inc. ( MTWO ) (“M2i Global”) today announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form S-4 relating to Volato’s proposed merger with M2i Global...
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
Apr 13, 2026
ALT5's core fintech platform continued to scale in 2025, supported by growth across payments, trading, and settlement processing of approximately $3.5 billion in transaction volume during the year ALT5 strengthened its operating foundation through compliance restoration, governance upgrades, and continued platform expansion following the acquisition of Mswipe Recent initiatives demonstrate the Company's strategy to extend its core institutional infrastructure into...
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
Apr 13, 2026
SANTIAGO, Chile, April 13, 2026 /PRNewswire/ -- Cencosud S.A. (the Company) today announced the tender results in connection with its offer to purchase for cash any and all of its outstanding 4.375% Notes due 2027 (the Notes) (the Offer). The Offer was made upon the terms and subject to the conditions (including the Financing Condition (as defined in the Offer...
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Apr 13, 2026
07:59 AM EDT, 04/13/2026 (MT Newswires) -- Spyre Therapeutics ( SYRE ) said Monday that its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its primary, and key secondary endpoints in a phase 2 trial. The biotech firm said SPY001 was generally well tolerated by patients in the study, with no major safety concerns reported so far. Spyre also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved